The global oligonucleotide synthesis market is growing at a significant rate, due to the mounting usage of synthesized oligonucleotides in molecular diagnostics and clinical applications, and intensifying demand for synthesized oligonucleotides. The market has witnessed high demand synthesized oligonucleotides due to its escalating number of applications of in diagnostics, research, and therapeutics.

Request to get a detailed TOC and free sample copy of this research report at https://www.vynzresearch.com/healthcare/oligonucleotide-synthesis-market/request-sample

On the basis of product, the market is subdivided into reagent, synthesized oligonucleotides, and equipment. On the basis of product, the synthesized oligonucleotides are further subdivided into primers, intermediate-scale synthesize oligonucleotides, probes, linkers & adaptors, and large-scale synthesis oligonucleotides. On the basis of the type, the synthesized oligonucleotides are further subdivided into custom oligonucleotides and pre-designed oligonucleotides. On the basis of application, the market is subdivided into research, therapeutic and diagnostics. The different end-users of the market are academic research institutes, diagnostic laboratories, pharmaceutical and biotechnology companies, and other end users.

Mounting usage of synthesized oligonucleotides in molecular diagnostics and clinical applications, the surge in venture capital investments, the mounting occurrence of cancer and infectious diseases, intensifying demand for synthesized oligonucleotides, and escalating government investments are the primary growth drivers for oligonucleotide synthesis market.

Explore full research report at https://www.vynzresearch.com/healthcare/oligonucleotide-synthesis-market

North America is the largest oligonucleotide synthesis market as in the region the research and development expenditure in the pharmaceutical and biotechnology companies are mounting. Asia-Pacific is observed to witness the fastest growth in the market, due to the mounting accessibility of synthesized oligos.

Key players in the oligonucleotide synthesis market are catering to the demand of these devices by investing on technologically advanced products in their product portfolio across the globe.

Merck KGaA, Agilent Technologies, LGC Biosearch Technologies, Eurofins Genomics, Eurogentec, GE Healthcare, Thermo Fisher Scientific, and Nitto Denko Avecia Inc. are the key players offering oligonucleotide synthesis.

Source: VynZ Research